The type IV pilin of Burkholderia mallei is highly immunogenic but fails to protect against lethal aerosol challenge in a murine model

Infection and Immunity

Volumn 75, Issue 6, 2007, Pages 3027-3032

  Fernandes, Paula J ^a,c   Guo, Qin ^a   Waag, David M ^b   Donnenberg, Michael S ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^c ASSOCIATION OF PUBLIC HEALTH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; HYPERIMMUNE GLOBULIN; PILIN;

ACTIVE IMMUNIZATION; AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BURKHOLDERIA MALLEI; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOGENICITY; LETHALITY; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROVOCATION TEST;

AEROSOLS; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; BURKHOLDERIA MALLEI; DISEASE MODELS, ANIMAL; FIMBRIAE PROTEINS; GLANDERS; MICE; TREATMENT FAILURE;

EID: 34249874581     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00150-07     Document Type: Article

References (27)

1. Amemiya, K., G. V. Bush, D. DeShazer, and D. M. Waag. 2002. Nonviable Burkholderia mallei induces a mixed Th1- and Th2-like cytokine response in BALB/c mice. Infect. Immun. 70:2319-2325.
2. Bartlett, J. G. 1992. Glanders, p. 1293-1295. In S. L. Gorbach, J. G. Bartlett, and N. R. Blacklow (ed.), Infectious diseases. W. B. Saunders Company, Philadelphia, PA.
3. Cachia, P. J., L. M. Glasier, R. R. Hodgins, W. Y. Wong, R. T. Irvin, and R. S. Hodges. 1998. The use of synthetic peptides in the design of a consensus sequence vaccine for Pseudomonas aeruginosa. J. Pept. Res. 52:289-299.
4. Craig, L., M. E. Pique, and J. A. Tainer. 2004. Type IV pilus structure and bacterial pathogenicity. Nat. Rev. Microbiol. 2:363-378.
5. Craig, L., N. Volkmann, A. S. Arvai, M. E. Pique, M. Yeager, E. H. Egelman, and J. A. Tainer. 2006. Type IV pilus structure by cryo-electron microscopy and crystallography: implications for pilus assembly and functions. Mol. Cell 23:651-662.
6. Daniel, A., A. Singh, L. J. Crowther, P. J. Fernandes, W. Schreiber, and M. S. Donnenberg. 2006. Interaction and localization studies of enteropathogenic Escherichia coli type IV bundle-forming pilus outer membrane components. Microbiology 152:2405-2420.
7. Egerton, J. R., P. T. Cox, B. J. Anderson, C. Kristo, M. Norman, and J. S. Mattick. 1987. Protection of sheep against footrot with a recombinant DNA-based fimbrial vaccine. Vet. Microbiol. 14:393-409.
8. Essex-Lopresti, A. E., J. A. Boddey, R. Thomas, M. P. Smith, M. G. Hartley, T. Atkins, N. F. Brown, C. H. Tsang, I. R. Peak, J. Hill, I. R. Beacham, and R. W. Titball 2005. A type IV pilin, PiIA, contributes to adherence of Burkholderia pseudomallei and virulence in vivo. Infect. Immun. 73:1260-1264.
9. Gill, S. C., and P. H. von Hippel. 1989. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182:319-326. (Erratum, 189:283, 1990.)
10. Hawley, R. J., and E. M. Eitzen, Jr. 2001. Biological weapons - a primer for microbiologists. Annu. Rev. Microbiol. 55:235-253.
11. Heine, H. S., M. J. England, D. M. Waag, and W. R. Byrne. 2001. In vitro antibiotic susceptibilities of Burkholderia mallei (causative agent of glanders) determined by broth microdilution and E-test. Antimicrob. Agents Chemother. 45:2119-2121.
12. Howe, C., and W. R. Miller. 1947. Human glanders: report of six cases. Ann. Intern. Med. 26:93-115.
13. Lepper, A. W., L. J. Moore, J. L. Atwell, and J. M. Tennent. 1992. The protective efficacy of pili from different strains of Moraxella bovis within the same serogroup against infectious bovine keratoconjunctivitis. Vet. Microbiol. 32:177-187.
14. Lepper, A. W. D., J. L. Atwell, P. R. Lehrbach, C. L. Schwartzkoff, J. R. Egerton, and J. M. Tennent. 1995. The protective efficacy of cloned Moraxella bovis pili in monovalent and multivalent vaccine formulations against experimentally induced infectious bovine keratoconjunctivitis (IBK). Vet. Microbiol. 45:129-138.
15. McGilvray, C. D. 1944. The transmission of glanders from horse to man. Can. J. Public Health 35:268-275.
16. Ramboarina, S., P. Fernandes, P. Simpson, G. Frankel, M. Donnenberg, and S. Matthews. 2004. Complete resonance assignments of bundlin (BfpA) from the bundle-forming pilus of enteropathogenic Escherichia coli. J. Biomol. NMR 29:427-428.
17. Ramboarina, S., P. J. Fernandes, S. Danieli, S. Islam, P. Simpson, G. Frankel, F. Booy, M. S. Donnenberg, and S. Matthews. 2005. Structure of the bundle-forming pilus from enteropathogenic Escherichia coli. J. Biol. Chem. 280:40252-40260.
18. Ribot, W. J., and R. L. Ulrich. 2006. The animal pathogen-like type III secretion system is required for the intracellular survival of Burkholderia mallei within J774.2 macrophages. Infect. Immun. 74:4349-4353.
19. Roy, C. J., M. Hale, J. M. Hartings, L. Pitt, and S. Duniho. 2003. Impact of inhalation exposure modality and particle size on the respiratory deposition of ricin in BALB/c mice. Inhal Toxicol. 15:619-638.
20. Srinivasan, A., C. N. Kraus, D. DeShazer, P. M. Becker, J. D. Dick, L. Spacek, J. G. Bartlett, W. R. Byrne, and D. L. Thomas. 2001. Glanders in a military research microbiologist. N. Engl. J. Med. 345:256-258.
21. Stewart, D. J., B. L. Clark, J. E. Peterson, D. L. Emery, E. F. Smith, D. A. Griffiths, and I. J. O'Donnell. 1985. The protection given by pilus and whole cell vaccines of Bacteroides nodosus strain 198 against ovine foot-rot induced by strains of different serogroups. Aust. Vet. J. 62:153-159.
22. Sun, D., J. M. Seyer, I. Kovari, R. A. Sumrada, and R. K. Taylor. 1991. Localization of protective epitopes within the pilin subunit of the Vibrio cholerae toxin-coregulated pilus. Infect. Immun. 59:114-118.
23. Trevino, S. R., A. R. Permenter, M. J. England, N. Parthasarathy, P. H. Gibbs, D. M. Waag, and T. C. Chanh. 2006. Monoclonal antibodies passively protect BALB/c mice against Burkholderia mallei aerosol challenge. Infect. Immun. 74:1958-1961.
24. Waag, D. M., and D. DeShazer. 2004. Glanders, new insights into an old disease, p. 209-238. In L. E. Lindler, F. J. Lebeda, and G. W. Korch (ed.), Biological weapons defense: infectious diseases and counterterrorism. Humana Press, Inc., Totowa, NJ.
25. Wheelis, M. 1998. First shots fired in biological warfare. Nature 395:213.
26. Wilkinson, L. 1981. Glanders: medicine and veterinary medicine in common pursuit of a contagious disease. Med. Hist. 25:363-384.
27. Zhang, H.-Z., and M. S. Donnenberg. 1996. DsbA is required for stability of the type IV pilin of enteropathogenic Escherichia coli. Mol. Microbiol. 21: 787-797.